Crinetics Pharmaceuticals, Inc. Research and Development Expense
Crinetics Pharmaceuticals, Inc. (CRNX) reported Research and Development Expense of $99.85 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-03
- Crinetics Pharmaceuticals, Inc. research and development expense for the quarter ending 2026-06-30 was $99.85M, a 24.34% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. research and development expense for the quarter ending 2026-03-31 was $100.08M, a 31.27% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. research and development expense for the quarter ending 2025-12-31 was $85.05M, a 27.77% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. research and development expense for the quarter ending 2025-09-30 was $90.46M, a 46.13% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. research and development expense for fiscal 2025 was $332.06M, a 38.27% increase from fiscal 2024.
- Crinetics Pharmaceuticals, Inc. research and development expense for fiscal 2024 was $240.16M, a 42.50% increase from fiscal 2023.
- Crinetics Pharmaceuticals, Inc. research and development expense for fiscal 2023 was $168.53M, a 29.41% increase from fiscal 2022.
- Crinetics Pharmaceuticals, Inc. research and development expense for fiscal 2022 was $130.22M, a 54.56% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $99.85M 10-Q · filed 2026-08-03 | $199.93M 10-Q · filed 2026-08-03 | $284.98M derived: sum of 3 quarters · filed 2026-08-03 | $375.45M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $100.08M 10-Q · filed 2026-05-07 | $185.13M derived: sum of 2 quarters · filed 2026-05-07 | $275.60M derived: sum of 3 quarters · filed 2026-05-07 | $355.90M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $85.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $175.52M derived: sum of 2 quarters · filed 2026-02-26 | $255.82M derived: sum of 3 quarters · filed 2026-08-03 | $332.06M 10-K · filed 2026-02-26 |
| 2025-09-30 | $90.46M 10-Q · filed 2025-11-06 | $170.76M derived: sum of 2 quarters · filed 2026-08-03 | $247.00M 10-Q · filed 2025-11-06 | $313.57M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $80.30M 10-Q · filed 2026-08-03 | $156.54M 10-Q · filed 2026-08-03 | $223.11M derived: sum of 3 quarters · filed 2026-08-03 | $285.01M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $76.24M 10-Q · filed 2026-05-07 | $142.81M derived: sum of 2 quarters · filed 2026-05-07 | $204.71M derived: sum of 3 quarters · filed 2026-05-07 | $263.06M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $66.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $128.47M derived: sum of 2 quarters · filed 2026-02-26 | $186.81M derived: sum of 3 quarters · filed 2026-02-26 | $240.16M 10-K · filed 2026-02-26 |
| 2024-09-30 | $61.91M 10-Q · filed 2025-11-06 | $120.25M derived: sum of 2 quarters · filed 2025-11-06 | $173.59M 10-Q · filed 2025-11-06 | $219.17M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $58.34M 10-Q · filed 2025-08-07 | $111.69M 10-Q · filed 2025-08-07 | $157.26M derived: sum of 3 quarters · filed 2026-02-26 | $201.10M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $53.34M 10-Q · filed 2025-05-08 | $98.92M derived: sum of 2 quarters · filed 2026-02-26 | $142.76M derived: sum of 3 quarters · filed 2026-02-26 | $183.40M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $45.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $89.42M derived: sum of 2 quarters · filed 2026-02-26 | $130.06M derived: sum of 3 quarters · filed 2026-02-26 | $168.53M 10-K · filed 2026-02-26 |
| 2023-09-30 | $43.84M 10-Q · filed 2024-11-12 | $84.48M derived: sum of 2 quarters · filed 2024-11-12 | $122.95M 10-Q · filed 2024-11-12 | $159.94M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $40.64M 10-Q · filed 2024-08-08 | $79.11M 10-Q · filed 2024-08-08 | $116.10M derived: sum of 3 quarters · filed 2025-02-27 | $148.09M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $38.47M 10-Q · filed 2024-05-09 | $75.46M derived: sum of 2 quarters · filed 2025-02-27 | $107.45M derived: sum of 3 quarters · filed 2025-02-27 | $140.44M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $36.99M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $68.98M derived: sum of 2 quarters · filed 2025-02-27 | $101.97M derived: sum of 3 quarters · filed 2025-02-27 | $130.22M 10-K · filed 2025-02-27 |
| 2022-09-30 | $31.99M 10-Q · filed 2023-11-07 | $64.98M derived: sum of 2 quarters · filed 2023-11-07 | $93.23M 10-Q · filed 2023-11-07 | $117.84M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $32.99M 10-Q · filed 2023-08-08 | $61.25M 10-Q · filed 2023-08-08 | $85.85M derived: sum of 3 quarters · filed 2024-02-28 | $107.43M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $28.25M 10-Q · filed 2023-05-09 | $52.86M derived: sum of 2 quarters · filed 2024-02-28 | $74.44M derived: sum of 3 quarters · filed 2024-02-28 | $94.92M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $24.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $46.18M derived: sum of 2 quarters · filed 2024-02-28 | $66.67M derived: sum of 3 quarters · filed 2024-02-28 | $84.25M 10-K · filed 2024-02-28 |
| 2021-09-30 | $21.58M 10-Q · filed 2022-11-14 | $42.07M derived: sum of 2 quarters · filed 2022-11-14 | $59.65M 10-Q · filed 2022-11-14 | $76.48M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $20.49M 10-Q · filed 2022-08-12 | $38.07M 10-Q · filed 2022-08-12 | $54.90M derived: sum of 3 quarters · filed 2023-02-28 | $68.60M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $17.58M 10-Q · filed 2022-05-12 | $34.41M derived: sum of 2 quarters · filed 2023-02-28 | $48.11M derived: sum of 3 quarters · filed 2023-02-28 | $60.72M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $16.83M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $30.53M derived: sum of 2 quarters · filed 2023-02-28 | $43.14M derived: sum of 3 quarters · filed 2023-02-28 | $57.00M 10-K · filed 2023-02-28 |
| 2020-09-30 | $13.70M 10-Q · filed 2021-11-05 | $26.31M derived: sum of 2 quarters · filed 2021-11-05 | $40.17M 10-Q · filed 2021-11-05 | $52.31M derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | $12.61M 10-Q · filed 2021-08-10 | $26.47M 10-Q · filed 2021-08-10 | $38.61M derived: sum of 3 quarters · filed 2021-08-10 | $50.44M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $13.86M 10-Q · filed 2021-05-06 | $26.00M derived: sum of 2 quarters · filed 2021-05-06 | $37.83M derived: sum of 3 quarters · filed 2021-05-06 | $48.11M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $12.14M 10-K · filed 2020-03-09 | $23.97M derived: sum of 2 quarters · filed 2020-11-06 | $34.25M derived: sum of 3 quarters · filed 2020-11-06 | $41.51M 10-K · filed 2022-03-30 |
| 2019-09-30 | $11.82M 10-Q · filed 2020-11-06 | $22.11M derived: sum of 2 quarters · filed 2020-11-06 | $29.36M 10-Q · filed 2020-11-06 | $37.01M derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | $10.29M 10-Q · filed 2020-08-07 | $17.54M 10-Q · filed 2020-08-07 | $25.19M derived: sum of 3 quarters · filed 2020-08-07 | $32.08M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | $7.25M 10-Q · filed 2020-05-08 | $14.91M derived: sum of 2 quarters · filed 2020-05-08 | $21.79M derived: sum of 3 quarters · filed 2020-05-08 | $27.01M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $7.65M 10-K · filed 2020-03-09 | $14.54M derived: sum of 2 quarters · filed 2020-03-09 | $19.76M derived: sum of 3 quarters · filed 2020-03-09 | $24.48M 10-K · filed 2021-03-30 |
| 2018-09-30 | $6.89M 10-K · filed 2020-03-09 | $12.11M derived: sum of 2 quarters · filed 2020-03-09 | $16.83M 10-Q · filed 2019-11-12 | $19.39M derived: sum of 4 quarters · filed 2020-03-09 |
| 2018-06-30 | $5.22M 10-K · filed 2020-03-09 | $9.94M 10-Q · filed 2019-08-13 | $12.50M derived: sum of 3 quarters · filed 2020-03-09 | $15.03M derived: sum of 4 quarters · filed 2020-03-09 |
| 2018-03-31 | $4.72M 10-K · filed 2020-03-09 | $7.28M derived: sum of 2 quarters · filed 2020-03-09 | $9.80M derived: sum of 3 quarters · filed 2020-03-09 | $11.89M derived: sum of 4 quarters · filed 2020-03-09 |
| 2017-12-31 | $2.56M 10-K · filed 2019-03-13 | $5.08M derived: sum of 2 quarters · filed 2019-03-13 | $7.17M derived: sum of 3 quarters · filed 2019-03-13 | $9.23M 10-K · filed 2020-03-09 |
| 2017-09-30 | $2.52M 10-K · filed 2019-03-13 | $4.61M derived: sum of 2 quarters · filed 2019-03-13 | $6.67M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $2.08M 10-K · filed 2019-03-13 | $4.15M 10-Q · filed 2018-08-30 | ||
| 2017-03-31 | $2.06M 10-K · filed 2019-03-13 | |||
| 2016-12-31 | $5.10M 10-K · filed 2019-03-13 |